Key Findings:  Statistics gathered from the registered medical cannabis user database from the state of Minnesota, USA, find that most use both cannabidiol (CBD) and tetrahydrocannabinol (THC), and the most common use was for pain. Other uses were cancer, muscle spasms, PTSD, HIV/AIDS, and seizures to name a few. Interestingly doses were more often lower than recommended Food and Drug Administration-approved dosages for approved indications.
Type of Study:  Meta-analysis
Study Sample Size:  11520
Study Result:  Positive
Study Location(s):  United States
Year of Pub:  2023
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Pharma THC, Pharma CBD
Phytocannabinoid Source:  Not Applicable
Route of Administration:  , Inhalation, Oral (Ingestion), Sublingual/Oromucosal, Topical